Transaction · 0001437749-26-018879

BRYNJELSEN SEAN

BRYNJELSEN SEAN, PRES, CEO, reported an open-market or private sale at Eton Pharmaceuticals, Inc. involving 148.000000 shares for an estimated $4835.16. Reported holdings after the transaction were 833694.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SPRES, CEO
ETONEton Pharmaceuticals, Inc.
Filing timeMay 29
Trade dateMay 28, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$30.45
Pre-filing
1mo ago -20.7%1w ago +14.9%1d ago +6.4%
Returns since
7d -4.3%30d +17.2%90d +107.0%180d +107.0%1y +107.0%

ETON price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ETON since 2026-05-29Filed 97 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001437749-26-018879
Common Stock
Transaction date
May 28, 2026
Filed May 29, 2026, 08:16 PM · 1d delay
Shares
148 sh
$3.26k per share
Estimated value
-$483k
Computed from shares × price
Holdings after
833k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President & CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The shares were sold in multiple trades at prices ranging from $31.59 to $32.55. The price above reflects the weighted average sales price.

  2. F2

    The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at…

Original filing · 0001437749-26-018879
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ETON